313 related articles for article (PubMed ID: 9266964)
1. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E
Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
5. Enhanced functional activity in thyroid adenomas in vitro.
Poertl S; Kirner J; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():39-40. PubMed ID: 8980999
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
Derwahl M; Kuemmel M; Goretzki P; Schatz H; Broecker M
Biochem Biophys Res Commun; 1993 Mar; 191(3):1131-8. PubMed ID: 8385451
[TBL] [Abstract][Full Text] [Related]
7. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
Fournes B; Monier R; Michiels F; Milgrom E; Misrahi M; Feunteun J
Oncogene; 1998 Feb; 16(8):985-90. PubMed ID: 9519872
[TBL] [Abstract][Full Text] [Related]
9. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
10. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features.
Arturi F; Capula C; Chiefari E; Filetti S; Russo D
Exp Clin Endocrinol Diabetes; 1998; 106(3):234-6. PubMed ID: 9710366
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
14. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
15. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5.
Karges B; Krause G; Homoki J; Debatin KM; de Roux N; Karges W
J Endocrinol; 2005 Aug; 186(2):377-85. PubMed ID: 16079263
[TBL] [Abstract][Full Text] [Related]
16. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
Hoelting T; Duh QY; Clark OH; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
18. The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.
Uyttersprot N; Allgeier A; Baptist M; Christophe D; Coppee F; Coulonval K; Deleu S; Depoortere F; Dremier S; Lamy F; Ledent C; Maenhaut C; Miot F; Panneels V; Parma J; Parmentier M; Pirson I; Pohl V; Roger P; Savonet V; Taton M; Tonacchera M; van Sande J; Wilkin F; Vassart G
Adv Second Messenger Phosphoprotein Res; 1997; 31():125-40. PubMed ID: 9344247
[No Abstract] [Full Text] [Related]
19. Contrasting effects of activating mutations of GalphaS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells.
Ludgate M; Gire V; Crisp M; Ajjan R; Weetman A; Ivan M; Wynford-Thomas D
Oncogene; 1999 Aug; 18(34):4798-807. PubMed ID: 10490813
[TBL] [Abstract][Full Text] [Related]
20. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
